ARTICLE | Clinical News
Bridion sugammadex regulatory update
September 28, 2015 7:00 AM UTC
FDA’s Anesthetic and Analgesic Drug Products Advisory Committee will meet on Nov. 6 to discuss an NDA from Merck for Bridion sugammadex to reverse neuromuscular blockade due to muscle relaxants rocuro...